EVANS JOHN M. (CEO) sold 2.8% of their position (30.08K shares) of BEAM THERAPEUTICS INC. on the open market
Open‑market sale worth $739.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/6/2026ACC: 0001193125-26-144086
DirectorOfficer· CEO
Since Feb 2020
-30.08K
Net shares
Net seller
$739.3K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
30.08K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−30.08K
Price / share
$24.58
Trade value
$739.32K
% of position
2.8%
4/1/2026
1.08M→1.05M
Total
Net shares
−30.08K
Net value
-$739.32K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/1/2026 | S · Sale | −30.08K | $24.58 | $739.32K | 2.8% | 1.08M | 1.05M |
| Total | −30.08K | -$739.32K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned103K
Total
103K indirect103K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 103K | Indirect |
| Total | 103K | 103K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported